secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001628280-24-027816
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine stockholders elect directors, approve officer liability limitation
--------------------------------------------------------------------------------

- Stockholders elected Wendy Chung, Kaye Foster, Keith Gottesdiener, and Jeffrey Marrazzo as Class II directors.
- Approved certificate amendment to limit officer liability as permitted by Delaware law with 91.5M votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024 with 106.9M votes for.
- Annual meeting held June 12, 2024; quorum of 107.1M shares represented.
- All proposals passed; no dissident activity or unexpected vote outcomes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/0001628280-24-027816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/prme-20240612.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-027816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer